Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and others in the Cambridge-London life sciences corridor, and wider local and international ecosystems.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a companyโ€™s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the regionโ€™s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

o2h co-discovery presents: Quiz Night with Cat

๐—ค๐˜‚๐—ถ๐˜‡ ๐—ก๐—ถ๐—ด๐—ต๐˜ ๐˜„๐—ถ๐˜๐—ต ๐—–๐—ฎ๐˜ | ๐—ผ๐Ÿฎ๐—ต ๐—ฐ๐—ผ-๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜†

โ€‹Join us for an evening of quiz, conversation and connection during ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ผ๐—ป ๐—ง๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ in Boston.

โ€‹On Monday, 28 September, from 6:00โ€“8:30 PM, weโ€™re bringing together scientists, biotech professionals and curious minds for a fun quiz spanning ๐—Ÿ๐—ถ๐—ณ๐—ฒ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€, ๐—•๐—ถ๐—ผ๐˜๐—ฒ๐—ฐ๐—ต, ๐—ฃ๐—ผ๐—ฝ ๐—–๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ, ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐—น ๐—ž๐—ป๐—ผ๐˜„๐—น๐—ฒ๐—ฑ๐—ด๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ผ๐—ฟ๐—ฒ.

โ€‹Hosted by Catherine Stace, ๐—ฉ๐—ฃ - ๐—•๐˜‚๐˜€๐—ถ๐—ป๐—ฒ๐˜€๐˜€ ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ & ๐—ฆ๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€๐—ต๐—ถ๐—ฝ๐˜€, the evening is all about friendly competition, unexpected questions and great conversations beyond the conference floor.

UK Life Sciences Innovation Signals 2026: Capital, Capability and the Race to Convert Innovation Into Impact

Download the UK Life Sciences Innovation Signals Report

The UK life sciences sector continues to attract investment, strengthen research capabilities and advance scientific innovation. The key question facing the market is no longer whether innovation is being created. It is whether innovation can be converted into commercial growth, healthcare adoption and measurable patient impact.

PIA Commercial Life Science Insurance Brokers-NEW WEBSITE

PIA Commercial are pleased to confirm the launch of our new website
As One Nucleus members we work closely with life science companies in the UK and overseas to establish the insurance protection they require, and meets those needs

Please have a look at the website which details how we can help you, and feel free to contact us by telephone , email, or via the website

Kind regards

One Nucleus Expands its Member Marketplace support through a new collaboration with o2h co-Discovery called Supernova

Cambridge, UK, 28 July 2026 - One Nucleus expands its portfolio of member benefits through o2h co-discovery bringing discounted exclusive access for eligible One Nucleus members to specialist in-vitro ADME and DMPK services designed to support early-stage drug discovery.


Data Protection Update 2026: What's Changed?

Join Cambridge Network to welcome Howes Percival as our speakers to explain how data protection law is changing and what you need to know now to comply.

Data Protection law is constantly evolving. The Data (Use and Access) Act 2025 (DUAA), which amends the UK GDPR and Data Protection Act 2018, implemented a number of changes during the early part of 2026 with the last provisions taking effect from 19 June. It introduced some new key changes for UK organizations.

Pioneer Group and Oxford Properties secure leading life sciences investment firm Syncona Investment Management Ltd at Victoria House

Pioneer Group and Oxford Properties have announced that Syncona Investment Management Ltd (SIML), a leading life science investment manager, is moving into Victoria House, a leading hub for life sciences in London.

Developed by Pioneer Group and Oxford Properties, Victoria House in Bloomsbury, London continues to build one of Londonโ€™s most inspiring life science communities, where an ever-growing number of pioneering organisations are driving innovation across science, biopharmaceuticals, gene therapies, synthetic biology and AI.

TBI-Reporter/NIHR HRC in Brain Injury: Industry Workshop on De-risking Drug and Technology Innovation in Traumatic Brain Injury

TBI is a leading cause of death and disability, costs the UK economy over ยฃ10 billion, and the global economy over $500 billion, annually. Outcomes from TBI are poor โ€“ even with โ€œmildโ€ TBI, 30% of patients show incomplete recovery at six months post-injury. The scope for improvement (and potential market opportunity) is substantial. While many past trials have failed, the substantial new knowledge provides a timely opportunity to address this issue.

One Nucleus Awards โ€“ Enter by 17 September 2026

The One Nucleus Awards has been integrated into the Genesis Conference, to recognise outstanding achievements across our ecosystem. All shortlisted companies will receive a free delegate pass and will be invited to pitch at the company showcase, plus having the opportunity to network with over 400 delegates.  

Deadline Approaching: โ€ฏEntries close on 17 September, enter here with our easy entry form.

Subscribe to